Blood transfusion and infection after cardiac surgery
- PMID: 23647857
- PMCID: PMC3992887
- DOI: 10.1016/j.athoracsur.2012.11.078
Blood transfusion and infection after cardiac surgery
Abstract
Cardiac surgery is the largest consumer of blood products in medicine; although believed life saving, transfusion carries substantial adverse risks. This study characterizes the relationship between transfusion and risk of major infection after cardiac surgery. In all, 5,158 adults were prospectively enrolled to assess infections after cardiac surgery. The most common procedures were isolated coronary artery bypass graft surgery (31%) and isolated valve surgery (30%); 19% were reoperations. Infections were adjudicated by independent infectious disease experts. Multivariable Cox modeling was used to assess the independent effect of blood and platelet transfusions on major infections within 60 ± 5 days of surgery. Red blood cells (RBC) and platelets were transfused in 48% and 31% of patients, respectively. Each RBC unit transfused was associated with a 29% increase in crude risk of major infection (p < 0.001). Among RBC recipients, the most common infections were pneumonia (3.6%) and bloodstream infections (2%). Risk factors for infection included postoperative RBC units transfused, longer duration of surgery, and transplant or ventricular assist device implantation, in addition to chronic obstructive pulmonary disease, heart failure, and elevated preoperative creatinine. Platelet transfusion decreased the risk of infection (p = 0.02). Greater attention to management practices that limit RBC use, including cell salvage, small priming volumes, vacuum-assisted venous return with rapid autologous priming, and ultrafiltration, and preoperative and intraoperative measures to elevate hematocrit could potentially reduce occurrence of major postoperative infections.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Blood transfusion and infection after cardiac surgery.Ann Thorac Surg. 2013 Jun;95(6):1855-8. doi: 10.1016/j.athoracsur.2013.03.047. Ann Thorac Surg. 2013. PMID: 23706420 No abstract available.
-
Reply: To PMID 23647857.Ann Thorac Surg. 2014 May;97(5):1852-3. doi: 10.1016/j.athoracsur.2014.02.015. Ann Thorac Surg. 2014. PMID: 24792288 No abstract available.
-
Implicating transfusions in infections after cardiac operations.Ann Thorac Surg. 2014 May;97(5):1852. doi: 10.1016/j.athoracsur.2013.10.105. Ann Thorac Surg. 2014. PMID: 24792289 No abstract available.
References
-
- Mehta RH, Sheng S, O'Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes. 2009;2:583–90. - PubMed
-
- Speiss BD. Transfusion and outcome in heart surgery. Ann Thorac Surg. 2002;74:986–7. - PubMed
-
- Thurer RL, Loop FD, Lytle BW, Cosgrove DM. The conservation of blood during cardiac surgery. Clin Cardiol. 1979;2:155–7. - PubMed
-
- Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg. 1986;152:479–82. - PubMed
-
- Vamvakas EC, Moore SB. Blood transfusion and postoperative septic complications. Transfusion. 1994;34:714–27. - PubMed
Publication types
MeSH terms
Grants and funding
- UM1 HL088963/HL/NHLBI NIH HHS/United States
- U01 HL088953/HL/NHLBI NIH HHS/United States
- U01 HL088957/HL/NHLBI NIH HHS/United States
- U01 HL088942/HL/NHLBI NIH HHS/United States
- U01 HL088955/HL/NHLBI NIH HHS/United States
- U01 HL088951/HL/NHLBI NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- U01 HL088925/HL/NHLBI NIH HHS/United States
- U01 HL088939/HL/NHLBI NIH HHS/United States
- U01 HL088963/HL/NHLBI NIH HHS/United States
- U01 HL088928/HL/NHLBI NIH HHS/United States
- UM1 HL088939/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
